JPRN-jRCT2080221493未知2 期
The clinical study to assess the efficacy, safety and pharmacokinetics of NS-304 in patients with pulmonary arterial hypertension (PAH)
IPPON SHINYAKU CO., LTD. / Actelion Pharmaceuticals Japan Ltd.0 个研究点目标入组 30 人开始时间: 2011年6月27日最近更新:
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Idiopathic pulmonary arterial hypertension (IPAH)
- •Heritable pulmonary arterial hypertension (HPAH)
- •Drug- and Toxin-induced pulmonary arterial hypertension
- •PAH associated with one of the following;
- •a) connective tissue disease
- •b) congenital heart disease (At least one year should be elapsed after pulmonary shunt at the time of each baseline measurement.)
- •c) HIV infection
排除标准
- 未提供
研究者
相似试验
已完成
3 期
A clinical Trial in patients with Vernal Keratoconjunctivitis. Clinical trial is to study efficacy, safety and tolerability of Tacrolimus Ophthalmic Suspension in comparison to Cyclosporine eye drops (reference product).CTRI/2010/091/001456Ajanta Pharma Ltd200
已完成
不适用
A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Productsensitive skinJPRN-UMIN000047956ION CORPORATIO35
已完成
2 期
se of Roselle in Bronchial asthma and MalnutritioCTRI/2020/08/027013DXN Manufacturing India Pvt Ltd12
已完成
2 期
se of Noni juice in Bronchial asthma and malnutritioCTRI/2020/08/027012DXN Manufacturing India Pvt Ltd12
已完成
4 期
effect of Kanak taila in reducing wrinkles and promoting skin brightening.CTRI/2021/09/036560Ms Ozone Pharmaceuticals Ltd50